stella
beta
Host Genome Methylation: a Screening Tool in Anal Cancer Detection — Stella
Home
/
Anal Cancer
/
Host Genome Methylation: a Screening Tool in Anal Cancer Detection
View on ClinicalTrials.gov
Recruiting
Back to Anal Cancer trials
Host Genome Methylation: a Screening Tool in Anal Cancer Detection
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(9 sites)
France
Cardiovascular Surgery and Transplantation Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Dermatology Department, Paris, Île-de-France Region
Gynecology and Obstetrics Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Hepato-Gastroenterology, Digestive Oncology, and Proctology Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Infectious and Tropical Diseases Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Nephrology Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Pathological Anatomy and Cytology Department Bichat-Claude Hospital, Paris, Île-de-France Region
Pulmonology B and Lung Transplantation Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region
Virology Department Bichat-Claude Bernard Hospital, Paris, Île-de-France Region